A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
TSIF
Ouch...thanks for the callout, but I'm not sure if I want the "credit" on this call... ;)
Highly volitile and calling botton in the biopharm family is pretty much impossible. I'm hoping that it gets some "love" soon after giving up so much after the reverse split. I'm hopeful what when the "D" comes off the end after the 30 day period following a reverse split that it will get a little bit more appreciation from the market! Good luck! (I'll apologize in advance if this one doesn't mature, but I have pretty good expectations it will sometime in the next few months...